Stopping a Trial for Futility: The Cooperative New Scandinavian Enalapril Survival Study II

Steven Snapinn and Curt D. Furberg
Additional contact information
Steven Snapinn: Amgen Inc.
Curt D. Furberg: Wake Forest University School of Medicine, Department of Public Health Sciences

Chapter Case 23 in Data Monitoring in Clinical Trials, 2006, pp 302-311 from Springer

Abstract: Abstract The Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) trial was designed to test the hypothesis that enalapril, an angiotensin-converting enzyme inhibitor, would reduce the risk of death in patients with an acute myocardial infarction. A sequential stopping rule that allowed for both early acceptance and early rejection of the null hypothesis, in the spirit of stochastic curtailment, was developed specifically for this trial. Very early in the trial the Data and Safety Monitoring Committee noticed an excess of mortality in the enalapril group. When this trend persisted, the committee first recommended protocol modifications, then termination of recruitment, and finally termination of the trial. The main reason was futility, as well as the possibility of harm, particularly in certain subgroups. This trial provides useful lessons regarding futility analyses, flexible monitoring rules, and the sponsor’s role on both the Data Monitoring Committee and the Steering Committee.

Keywords: Acute Myocardial Infarction; Steering Committee; Case Study Approach; Monitoring Committee; Data Monitoring Committee (search for similar items in EconPapers)
Date: 2006
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-0-387-30107-5_29

Ordering information: This item can be ordered from
http://www.springer.com/9780387301075

DOI: 10.1007/0-387-30107-0_29

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().